Health News

At The Medicine Shoppe® Pharmacies, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.


Rx to Reverse Neuromuscular Blocking Approved
The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.
Flu Shot Less Effective in Seniors — Here's Why
Flu vaccines are known to be less effective in the elderly. But until now, the mechanisms behind this phenomenon were not well-understood.
A Hormone Therapy Benefit for Postmenopausal Women
Hormone therapy is often used to ease symptoms like hot flashes in postmenopausal women. But this practice may have another benefit.
Breast Cancer Rxs Go Head to Head
The current front-line treatment for early breast cancer, tamoxifen, may have met its match.
Protecting the Heart During Chemo
Chemotherapy can greatly improve cancer patients' chances of survival. But with this treatment comes a serious and equally life-threatening risk: heart failure.
A New Option for ALK-Positive Lung Cancer
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).
Chemo Overdose Rx Approved
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
Pediatric Ear Rx Gets FDA Nod
SAN DIEGO, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced that the U.S. Food and Drug Administration (FDA) has approved OTIPRIO (ciprofloxacin otic suspension) for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement.
When Chemo Fails, This Rx May Help
Breast cancer patients and their doctors may now have a new tool in their toolbox.
No Shortage of Hepatitis C Treatments
In the last three years, there have been many advances in hepatitis C treatment. Hepatitis C is an infection that affects the liver and can lead to liver disease if left untreated.
<< first189190191192193194195196197last >>

REFINE